Department of Cardiology, Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands.
Clinic III for Internal Medicine, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Catheter Cardiovasc Interv. 2023 Nov;102(6):1140-1148. doi: 10.1002/ccd.30816. Epub 2023 Sep 5.
Preprocedural computed tomography planning improves procedural safety and efficacy of transcatheter aortic valve implantation (TAVI). However, contemporary imaging modalities do not account for device-host interactions.
This study evaluates the value of preprocedural computer simulation with FEops HEARTguide on overall device success in patients with challenging anatomies undergoing TAVI with a contemporary self-expanding supra-annular transcatheter heart valve.
This prospective multicenter observational study included patients with a challenging anatomy defined as bicuspid aortic valve, small annulus or severely calcified aortic valve. We compared the heart team's transcatheter heart valve (THV) planning decision based on (1) conventional multislice computed tomography (MSCT) and (2) MSCT imaging with FEops HEARTguide simulations. Clinical outcomes and THV performance were followed up to 30 days.
A total of 77 patients were included (median age 79.9 years (IQR 74.2-83.8), 42% male). In 35% of the patients, preprocedural planning changed after FEops HEARTguide simulations (change in valve size selection [12%] or target implantation height [23%]). A new permanent pacemaker implantation (PPI) was implanted in 13% and >trace paravalvular leakage (PVL) occurred in 28.5%. The contact pressure index (i.e., simulation output indicating the risk of conduction abnormalities) was significantly higher in patients with a new PPI, compared to those without (16.0% [25th-75th percentile 12.0-21.0] vs. 3.5% [25th-75th percentile 0-11.3], p < 0.01) The predicted PVL was 5.7 mL/s (25th-75th percentile 1.3-11.1) in patients with none-trace PVL, 12.7 (25th-75th percentile 5.5-19.1) in mild PVL and 17.7 (25th-75th percentile 3.6-19.4) in moderate PVL (p = 0.04).
FEops HEARTguide simulations may provide enhanced insights in the risk for PVL or PPI after TAVI with a self-expanding supra-annular THV in complex anatomies.
经导管主动脉瓣植入术(TAVI)前的计算机断层扫描规划可提高手术安全性和疗效。然而,目前的影像学手段并未考虑到器械与宿主之间的相互作用。
本研究旨在评估在接受经导管自膨式瓣上心脏瓣膜治疗的复杂解剖结构患者中,使用 FEops HEARTguide 进行术前计算机模拟对整体器械成功的价值。
本前瞻性多中心观察性研究纳入了具有挑战性解剖结构的患者,这些患者的解剖结构定义为二叶式主动脉瓣、瓣环较小或主动脉瓣严重钙化。我们比较了心脏团队基于(1)传统多层螺旋计算机断层扫描(MSCT)和(2)FEops HEARTguide 模拟的 MSCT 成像做出的经导管心脏瓣膜(THV)规划决策。临床结局和 THV 性能随访 30 天。
共纳入 77 例患者(中位年龄 79.9 岁(IQR 74.2-83.8),42%为男性)。在 35%的患者中,FEops HEARTguide 模拟后改变了术前规划(瓣膜尺寸选择改变[12%]或目标植入高度改变[23%])。13%的患者新植入永久性起搏器,28.5%的患者发生微量瓣周漏(PVL)。与无新起搏器植入的患者相比,新植入起搏器的患者接触压力指数(即表示传导异常风险的模拟输出)明显更高,分别为 16.0%(25th-75th 分位数 12.0-21.0)和 3.5%(25th-75th 分位数 0-11.3)(p<0.01)。无微量 PVL 的患者预测 PVL 为 5.7 mL/s(25th-75th 分位数 1.3-11.1),轻度 PVL 为 12.7(25th-75th 分位数 5.5-19.1),中度 PVL 为 17.7(25th-75th 分位数 3.6-19.4)(p=0.04)。
FEops HEARTguide 模拟可能为复杂解剖结构中经导管自膨式瓣上心脏瓣膜治疗后的微量瓣周漏或永久性起搏器植入风险提供更深入的见解。